Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

CardioComm Solutions Inc V.EKG

Alternate Symbol(s):  EKGGF

Healthcare Medical Devices
CardioComm Solutions, Inc. is a global medical provider of consumer heart monitoring and medical electrocardiogram (ECG) software solutions. The Company’s technology is used in products for recording, viewing, analyzing and storing electrocardiograms for diagnosis and management of cardiac patients. It develops advanced software, hardware and core laboratory reading services related to ECG and ambulatory arrhythmia monitoring systems for medical and consumer markets globally. Its Global ECG Management Solutions (GEMS) and GlobalCardio (Cloud based GEMS) products are licensed worldwide to hospitals, ECG commercial reading services and physicians. The Company is also engaged in manufacturing, marketing, and sales of personal ECG monitors direct to consumers. The products are marketed under the HeartCheck brand. It has developed compatibility of the HeartCheck device to its GEMS and GlobalCardio based software to enable use of the device for remote ECG/arrhythmia monitoring services.


TSXV:EKG - Post by User

CardioComm Solutions Inc
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(3)
•••
Post by officeman213on Oct 05, 2023 6:29pm
292 Views
Post# 35672148

Announcement of trading resumption

Announcement of trading resumption
   
Canadian Investment Regulatory Organization Trade Resumption - EKG
2023-10-05 04:09:00 PM ET (CW)
   
   
Canadian Investment Regulatory Organization Trade Resumption - EKG VANCOUVER, BC, Oct. 5, 2023 Trading resumes in: Company:  CardioComm Solutions, Inc. TSX-Venture Symbol: EKG All Issues: Yes Resumption (ET): 9:30 AM 10/6/2023  CIRO can make a decision to impose a temporary suspension (halt) of trading in a security of a publicly-listed company. Trading halts are implemented to ensure a fair and orderly market. CIRO is the national self-regulatory organization which oversees all investment dealers and trading activity on debt and equity marketplaces in Canada. SOURCE Canadian Investment Regulatory Organization (CIRO) -- Halts/Resumptions  View original content: https://www.newswire.ca/en/releases/archive/October2023/05/c5801.html For further information about CIRO's trading halt policy, please see Trading Halts &amp; Timely Disclosure at www.iiroc.ca under the Markets tab. Please note that CIRO staff cannot provide any information about a specific halt beyond what is contained in this halt notice. For general information about CIRO, contact CIRO's Complaints &amp; Inquiries team by submitting a Secure Form located on our contact page at www.iiroc.ca or dialing 1-877-442-4322 (Option 1). For company-related enquiries, please contact the company directly. Copyright CNW Group 2023 (END) Dow Jones Newswires  October 05, 2023 16:09 ET (20:09 GMT)
 

<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities